Mevalonate Pathway Regulates Cell Size Homeostasis and Proteostasis through Autophagy

Teemu P Miettinen1, Mikael Björklund1

  • 1Division of Cell and Developmental Biology, School of Life Sciences, University of Dundee, DD1 5EH Dundee, Scotland, UK.

Cell Reports
|December 22, 2015
PubMed

Insights

Statins, used to inhibit the mevalonate pathway, decrease cell proliferation and increase cell size and protein density. This occurs via geranylgeranylation of RAB11, regulating autophagy and cell size homeostasis.

Area of Science:

  • Cell Biology
  • Metabolic Pathways
  • Drug Discovery

Background:

  • Cell size homeostasis relies on balancing cell growth and proliferation.
  • The role of metabolic pathways in maintaining this balance is not well understood.

Purpose of the Study:

  • To investigate the effects of clinically used drugs on cell size.
  • To identify metabolic regulators of cell size and proteostasis.

Main Methods:

  • Screening a library of clinical drug molecules for their impact on cell size.
  • Utilizing various cell types, including primary human cells.
  • Investigating the role of geranylgeranylation and the small GTPase RAB11.

Main Results:

  • Statins, inhibitors of the mevalonate pathway, were found to reduce cell proliferation.
  • Statins increased cell size and cellular protein density across multiple cell types.
  • Mevalonate pathway's influence on cell size and protein density is mediated by RAB11 geranylgeranylation, impacting autophagic flux.

Conclusions:

  • The mevalonate pathway is identified as a key metabolic regulator of autophagy.
  • Inhibition of an anabolic pathway paradoxically leads to increased cell size and protein density, highlighting complex regulation of proteostasis.

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
6.1K
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
2.0K
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.5K
The Proteasome02:18

The Proteasome

5.1K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
10.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K